These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 3776768

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [A clinical evaluation of CS-807 in patients with urinary tract infections].
    Nakajima K, Oshinoya Y, Uchibayashi T, Ohkawa M, Hisazumi H.
    Hinyokika Kiyo; 1988 Aug; 34(8):1515-8. PubMed ID: 3195413
    [Abstract] [Full Text] [Related]

  • 3. [Long-term treatment and clinical evaluation of enoxacin in complicated urinary tract infections].
    Washida H, Sakagami H, Iwase Y, Sasaki S.
    Hinyokika Kiyo; 1987 Sep; 33(9):1508-12. PubMed ID: 3481218
    [Abstract] [Full Text] [Related]

  • 4. [Concomitant therapy with cefmenoxime and cefsulodin for refractory complicated urinary tract infection (especially caused by Pseudomonas aeruginosa)].
    Ishigami J, Fujii A, Harada M, Arakawa S, Umezu K, Kawabata G, Kataoka N, Kamidono S, Miyazaki S, Takasaki N.
    Hinyokika Kiyo; 1986 May; 32(5):779-88. PubMed ID: 3463188
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Clinical studies on enoxacin in urinary tract infection].
    Nagai N, Kaneko S, Akiyama T, Kurita T, Iguchi M, Kataoka K.
    Hinyokika Kiyo; 1988 Jul; 34(7):1283-91. PubMed ID: 3051955
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Clinical experience of norfloxacin in urinary tract infection].
    Banya Y, Funaki H, Takagane H, Tanji S, Abe T, Aoki H, Kubo T, Ohori T.
    Hinyokika Kiyo; 1985 Aug; 31(8):1501-17. PubMed ID: 4083210
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Microorganisms isolated from urinary tract infection and their beta-lactamase production and evaluation of clinical efficacy of sulperazone].
    Kawamura J, Hayashi N, Okabe S, Kawahara S, Chigusa I, Araki T, Saito K, Takeno K, Suzuki N, Suzuki I.
    Hinyokika Kiyo; 1988 Aug; 34(8):1503-14. PubMed ID: 3057834
    [Abstract] [Full Text] [Related]

  • 17. [Clinical experience with ceftibuten in complicated urinary tract infections].
    Mizutani S, Nishimura K, Yoshimura K, Miyoshi S, Iwao N, Higashimoto J, Shiota K.
    Jpn J Antibiot; 1990 May; 43(5):779-89. PubMed ID: 2391749
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Clinical evaluation of cefazedon on patients with urinary tract infections (author's transl)].
    Lenzner A, Koch E.
    Med Klin; 1979 May 25; 74(21):834-8. PubMed ID: 112365
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.